Conference Presentations

American Heart Association EPI | Lifestyle. 2023. Travel time to specialty care and risk of death for children with CHD. Boston, MA, Feb 28-Mar 2, 2023. (Poster)

American Heart Association Scientific Sessions. 2022. Specialty care visits and likelihood of mortality for children with congenital heart disease. Chicago, IL, Nov 5-7, 2022. (Podium)

American Heart Association Quality of Care and Outcomes Research Conference. 2022. Population based estimates of the prevalence of children with congenital heart disease. Reston, VA, May 13-14, 2022. (Poster)

American Heart Association Epi | Lifestyle Scientific Sessions. 2021. Validating the utility of plasma biomarkers in the prediction of readmission or mortality following congenital heart surgery. Virtual. May 20-21, 2021. (Poster)

Society of Thoracic Surgeons (STS) 55th Annual Conference. 2019. Evaluating the Utility of Biomarkers to Improve Prediction of One-Year Readmission or Mortality after Pediatric Congenital Heart Surgery. San Diego, California, January 27-29, 2019. (Poster)

Pediatric Academic Societies (PAS) Regional 1 Conference. 2019. Urban-Rural Disparities in Healthcare Utilization by Children with Medical Complexity. Boston, MA, March 18, 2019. (Podium)

Pediatric Academic Societies (PAS). 2019. Urban-Rural Disparities in Healthcare Utilization by Children with Medical Complexity. Baltimore, MD, April 27 – 29, 2019. (Poster)

Northeast Regional IDeA Conference (NERIC). 2019. Evaluating the Utility of Biomarkers to Improve Prediction of One-Year Readmission or Mortality after Pediatric Congenital Heart Surgery. Bretton Woods, NH, August 14-16, 2019. (Poster)

Southern Thoracic Surgical Association (STSA) 66th Annual Meeting. 2019. ST2 as a Predictor of Long-Term Risk of Unplanned Readmission After Pediatric Congenital Heart Surgery. Marco Island, FL, November 6 – 9, 2019. (Podium)

Sixth Scientific Meeting of The World Society for Pediatric and Congenital Heart Surgery (WSPCHS). 2018. The association between novel cardiac biomarker NT-proBNP and 30-day readmission or mortality after cardiac surgery in pediatric patients. Orlando, FL, July 24 – 26, 2018. (Poster)

American Heart Association Scientific Sessions. 2018. The association between novel cardiac biomarkers and 30-day readmission or mortality after cardiac surgery in pediatric patients. Chicago, IL, November 10–12, 2018. (Poster)

American Heart Association Scientific Sessions. 2018. Galectin-3 as a Predictor of Long-term Survival and Adverse Outcomes after Adult Cardiac Surgery. Chicago, IL, November 10–12, 2018. (Poster)